Старение. Профессиональный врачебный подход

   67. Feudjo-Tepie M.A., Le Roux G., Beach K.J., Bennett D., Robinson N.J. Comorbidities of Idiopathic Thrombocytopenic Purpura: A Population-Based Study // Advances in Hematology, 2009.

   68. Fialova D., Onder G. Medication errors in elderly people: contributing factors and future perspectives.Br J Clin Pharmacol. 2009 Jun;67(6):641-5

   69. Findley P., Shen C., Sambamoorthi U. Multimorbidity and persistent depression among veterans with diabetes, heart disease, and hypertension.Health Soc Work. 2011 May;36(2):109-19.

   70. Fortin M., Bravo G., Hudon C., Vanasse A., Lapointe L. Prevalence of multimorbidity among adults seen in family practice // Ann Fam Med, 2005; 3: 223-8

   71. Fortin M., Dionne J., Pinho G., Gignac J., Almirall J., Lapointe L. Randomized clinical trials: Do they have external v alidity for patients with multiple comorbidities? // Ann Fam Med, 2006; 4:104-8

   72. Fortin M., Lapointe L., Hudon C., Vanasse A. Multimorbidity in medical literature: Is it commonly researched? // Can Fam Physician, 2005; 51:244–245.

   73. Fortin M., Lapointe L., Hudon C., Vanasse A. Multimorbidity in the medical literature: a bibliometric study // Can Fam Physician, 2004

   74. Freeman J.T. Aging: Its History and Literature. – N. Y.; L.: Human Sciences Press, 1979. 161 p.

   75. Frieling T. Age-related functional gastrointestinal disorders. Z Gastroenterol. 2011 Jan;49(1): 47–53.

   76. Fuchs Z., Blumstein T., Novikov I. Morbidity, comorbidity, and their association with disability among community-dwelling oldest in Israel // J Gerontol A Biol Sci Med Sci. 1998; 53A(6):M447-M455

   77. Gavrilova N.S., Gavrilov L.A. et al. Evolution, mutations, and human longevity: Euro pean royal and noble families // Human Biol. 1998. Vol. 70. P. 799–804.

   78. Gijsen R., Hoeymans N., Schellevis F.G., Ruwaard D., Satariano W.A. Causes and consequences of comorbidity: a review // Journal of Clinical Epidemiology, 2001; July. Vol. 54, issue 7, p. 661–674.

   79. Gill T., Feinstein A.R. A critical appraisal of the quality-of-life measurements // JAMA, 1994; 272: 619–626.

   80. Gladyshev G.P. Thermodynaniics theory of biological evolution and aging. Su-pramolecular thermodynamics is a key to understanding phenomena of life. What is life from a physical chemist’s viewpoint // Успехи геронтологии 2002. Т. 9. С. 49–53.

   81. Globerson A. R., Abel E.L., Ben-Menahem D. Developmental aspects of T-lym-phocytes in aging // Goldstein A. L., ed. Biornedical Advances in Aging. New York; London: Plenum Press, 1990. P. 363–373.

   82. Gompertz B. On the Nature of the Function Expressive of the Law of Human Mortality. Phil. Trans. Royal Soc. (London). 1825.

   83. Gonzalez-Suarez E., Samper E., Flores J.M., Blasco M.A. Teomerase-deficient mice with short telomeres are resistant to skin tomorigenesis. Nature Genet. 2000. Vol. 26. P. 114–117.

   84. Greenfield S., Apolone G. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: Comorbidity and outcomes after hip replacement // Med Care, 1993; 31:141–154

   85. Grimby A., Svanborg A. Morbidity and health-related quality of life among ambulant elderly citizens // Aging, 1997; 9:356-364

   86. Grolla D.L., Tob T., Bombardierc C., Wright J.G. The development of a comorbidity index with physical function as the outcome // Journal of Clinical Epidemiology, 2005; June; volume 58, issue 6, p. 595–602.

   87. Hanaki Y., Sugiyama S., Ozaw a T. Effect of 3-(2,2,2-trimelhylhydrazinium) propionate, gamma-butyrobetaine hydroxylase inhibitor, on isoproterenol – induced mitochondrial dysfunction // Res. Commun. Chem. Phatol. Pharmacol. 1999; 64: 157–160.

   88. Harboun M., Ankri J. Comorbidity indexes: review of the literature and application to the elderly population // Rev Epidemiol Sante Publique, 2001; Jun;49(3):287–98.

   89. Harman D. Extending functional life span. Exp. Gerontol. 1998. Vol.33. P. 95–112.

   90. Hasty P., Camptsi J., Hoeijmakers J. et al. Aging and genome maintenance: lessons from the mouse? Science. 2003. Vol. 299. P. 1355–1359.

   91. Hayfiick L. How and why we age. Exp. Cerontol. 1998. Vol. 33. P. 639–653.

   92. Hayflick L., Moorhead P. S, The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961. Vol. 25. P. 585–621.

   93. Hayftick L. New approaches to old age. Nature. 2000. Vol. 403. P. 365.

   94. Hoffman C., Rice D., Sung H.Y. Persons with chronic conditions. Their prevalence and costs // JAMA, 1996; 13;276(18): 1473-9.

   95. Holden L., Scuffham P.A., Hilton M.F., Muspratt A, Ng S.K., Whiteford H.A. Patterns of multimorbidity in working Australians. Popul Health Metr. 2011 Jun 2;9(1): 15.

   96. Hunger M., Thorand B., Schunk M., Döring A., Menn P., Peters A., Holle R. Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study.Health Qual Life Outcomes. 2011. Jul 18; 9: 53.

   97. Increased multimorbidity in patients in general practice in the period 2003–2009. Ned Tijdschr Geneeskd. 2011; 155(26): A3109. Dutch.